Abstract
Pregnancies at risk of being associated with (open) neural tube defects can be identified by maternal serum and amniotic-fluid alphafetoprotein (AFP) concentrations in excess of established screening cut-off valves in conjunction with the results of an amniotic fluid electrophoretic acetylcholinesterase screening test. The risk associated with the AFP cut-off values are formulated in terms of a population screening programme. These "population risks" are of little value in the assessment of test results from individual "at-risk" pregnancies, especially when the observed AFP concentrations are in proximity to the "cut-off" values. A complete risk assessment procedure for individual pregnancies is described and presented in graphical form to permit immediate access by clinical staff.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson J. A., Boyle J. A. Computer diagnosis: statistical aspects. Br Med Bull. 1968 Sep;24(3):230–235. doi: 10.1093/oxfordjournals.bmb.a070641. [DOI] [PubMed] [Google Scholar]
- Davidson R. G., Walker W. H. alpha-Fetoprotein and antenatal screening. Clin Chim Acta. 1980 Jul 17;105(1):1–3. doi: 10.1016/0009-8981(80)90086-8. [DOI] [PubMed] [Google Scholar]
- Wald N. J., Cuckle H. S. Alpha fetoprotein in the antenatal diagnosis of open neural tube defects. Br J Hosp Med. 1980 May;23(5):473-4, 476, 478-80 passim. [PubMed] [Google Scholar]